Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 2,308,190 | 2,308,190 | 0 | $95.97M | $65.44M | 39.83% | -$30.54M |
| Personalis, Inc.(PSNL) | 14,044,943 | 14,044,943 | 0 | $81.18M | $49.30M | 30.01% | -$31.88M |
| Kymera Therapeutics, Inc.(KYMR) | 772,165 | 772,165 | 0 | $31.06M | $21.13M | 12.86% | -$9.93M |
| Entrada Therapeutics, Inc.(TRDA) | 1,739,768 | 1,739,768 | 0 | $30.08M | $15.73M | 9.57% | -$14.35M |
| Alector Inc | 3,545,719 | 3,545,719 | 0 | $6.70M | $4.36M | 2.65% | -$2.34M |
| Evaxion Biotech A/sADS | 542,279 | 1,214,126 | +671,847 | $458.4K | $2.25M | 1.37% | +$1.79M |
| Sutro Biopharma, Inc.(STRO) | 2,723,509 | 2,723,509 | 0 | $5.01M | $1.77M | 1.08% | -$3.24M |
| Lava Therapeutics NvSHS | 1,149,345 | 1,149,345 | 0 | $1.09M | $1.46M | 0.89% | +$366.6K |
| Viridian Therapeutics, Inc.(VRDN) | 93,414 | 93,414 | 0 | $1.79M | $1.26M | 0.77% | -$531.5K |
| Xilio Therapeutics, Inc.(XLO) | 1,483,758 | 1,483,758 | 0 | $1.42M | $1.07M | 0.65% | -$342.2K |
| Carisma Therapeutics Inc | 1,473,240 | 1,473,240 | 0 | $617.0K | $456.7K | 0.28% | -$160.3K |
| Neuphoria Therapeutics Inc | 10,027 | 10,027 | 0 | $34.4K | $57.8K | 0.04% | +$23.4K |
| Absci Corporation | 998,163 | 0 | -998,163 | $2.62M | $0 | — | -$2.62M |